Offer - Urjas Oil for just ₹ 1
Gesry H 250 Injection 1 Ml, a prescription drug, is manufactured in various forms such as Injection. Primarily, it is used for the treatment of Premature Labor.
Medical history of the patient along with age and gender determines the dosage of Gesry H 250 Injection 1 Ml. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Gesry H 250 Injection 1 Ml side effects, there are can be others also. These have been listed below. Such side effects of Gesry H 250 Injection 1 Ml normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Gesry H 250 Injection 1 Ml has a Severe effect for pregnant women and Severe effect on lactating mothers. Warnings related to Gesry H 250 Injection 1 Ml's effects on the liver, heart and kidney, if any, have been listed below.
Gesry H 250 Injection 1 Ml is not recommended if you suffer from certain medical conditions as it can have adverse effects. Blood Clotting Disorders, Breast Cancer, Liver Disease are examples of such conditions. Other conditions have been mentioned below in the Gesry H 250 Injection 1 Ml contraindications section.
Additionally, Gesry H 250 Injection 1 Ml may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Gesry H 250 Injection 1 Ml is considered not safe while driving, and is not addictive.
Gesry H 250 Injection 1 Ml is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult(Female) |
|
Is the use of Gesry H 250 Injection 1 Ml safe for pregnant women?
Gesry H has many dangerous side effects in pregnant women. If you are pregnant, do not consume Gesry H without medical advice.
Is the use of Gesry H 250 Injection 1 Ml safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Gesry H. It should only be taken after medical advice.
What is the effect of Gesry H 250 Injection 1 Ml on the Kidneys?
Very few cases of side effects of Gesry H on kidney have been reported.
What is the effect of Gesry H 250 Injection 1 Ml on the Liver?
The liver can be affected by Gesry H. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Gesry H only after medical advice.
What is the effect of Gesry H 250 Injection 1 Ml on the Heart?
Gesry H may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Gesry H 250 Injection 1 Ml unless your doctor advises you to do so -
Is this Gesry H 250 Injection 1 Ml habit forming or addictive?
Forming a habit of Gesry H 250 Injection 1 Ml has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Gesry H 250 Injection 1 Ml you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Gesry H 250 Injection 1 Ml only on doctor's advice.
Is it able to treat mental disorders?
No, Gesry H 250 Injection 1 Ml is not used to treat mental disorders.
Interaction between Food and Gesry H 250 Injection 1 Ml
Due to the absence of research, it is difficult to say how Gesry H 250 Injection 1 Ml and food will interact.
Interaction between Alcohol and Gesry H 250 Injection 1 Ml
Information about the interaction of Gesry H 250 Injection 1 Ml and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 663-664
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Makena® (hydroxyprogesterone caproate)
